Prolonged clinical response to trabectedin in a heavily pretreated patient with advanced uterine leiomyosarcoma: A case report and literature review

2011 ◽  
Vol 121 (2) ◽  
pp. 416-417 ◽  
Author(s):  
Giacomo Corrado ◽  
Vanda Salutari ◽  
Gilda Fuoco ◽  
Alessandro Lucidi ◽  
Gabriella Ferrandina
2016 ◽  
Vol 10 (1) ◽  
Author(s):  
Debora de Melo Gagliato ◽  
Rudinei Diogo Marques Linck ◽  
Regis Otaviano Franca Bezerra ◽  
Mirela Souto ◽  
Gabriel Lima Lopes ◽  
...  

2017 ◽  
Vol 34 (3) ◽  
pp. 192-194 ◽  
Author(s):  
Paola Modaffari ◽  
Marta D’alonzo ◽  
Marta Garbagnati ◽  
Silvia Pecchio ◽  
Guido Menato ◽  
...  

2016 ◽  
Vol 102 (2_suppl) ◽  
pp. S90-S92 ◽  
Author(s):  
Grazia Artioli ◽  
Lucia Borgato ◽  
Sara Calamelli ◽  
Giuseppe Azzarello

2017 ◽  
Vol 03 (01) ◽  
Author(s):  
Hassaniya Zmaimita ◽  
Hamza Samlali ◽  
Awatif Rachdi ◽  
Amina Taleb ◽  
Zineb Bouchbika ◽  
...  

2020 ◽  
Vol 48 (10) ◽  
pp. 030006052094210
Author(s):  
Junyan Li ◽  
Xuejun Chen ◽  
Xiaoye Hu

Uterine leiomyosarcoma has the characteristics of high malignancy, a poor prognosis, and a high recurrence rate. Surgery is the main treatment option, supplemented by chemotherapy and radiotherapy. We report on a patient with recurrent uterine leiomyosarcoma who was treated with high-intensity focused ultrasound combined with chemotherapy. Tumor growth was controlled and the patient’s survival time was prolonged. High-intensity focused ultrasound combined with chemotherapy may thus provide a new treatment strategy for patients with recurrent and surgically difficult uterine leiomyosarcoma.


2020 ◽  
Vol Volume 13 ◽  
pp. 9849-9856 ◽  
Author(s):  
Jianzhen Shan ◽  
Jian Ruan ◽  
Yanbin Tan ◽  
Li Yan ◽  
Songan Chen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document